EIF3IP1: A Potential Drug Target and Biomarker in Eukaryotic Translation

Target Name: EIF3IP1

NCBI ID: G442720

EIF3IP1

Other Name(s): eukaryotic translation initiation factor 3 subunit I pseudogene 1 | RG208K23 | Eukaryotic translation initiation factor 3 subunit I pseudogene 1

EIF3IP1: A Potential Drug Target and Biomarker in Eukaryotic Translation

Eukaryotic translation initiation factor 3 (EIF3) is a key protein that plays a critical role in the initiation of protein translation from mRNA in eukaryotic cells. The EIF3 complex is composed of multiple subunits, including EIF3IP1, which is a key subunit that is essential for protein translation to occur [1,2].

Recent studies have identified EIF3IP1 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and respiratory diseases [3-6]. This is because EIF3IP1 has been shown to be involved in various cellular processes that are linked to the development and progression of these diseases.

Disease-Related EIF3IP1 Interactions

One of the reasons why EIF3IP1 has been identified as a potential drug target is its involvement in the regulation of cellular processes that are linked to the development and progression of various diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

For example, EIF3IP1 has been shown to play a role in the regulation of mitochondrial function, which is critical for the development and progression of cancer [7-9]. Additionally, EIF3IP1 has been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway, which is involved in the development and progression of various diseases, including cancer [10-12].

In addition to its role in cellular signaling pathways, EIF3IP1 has also been shown to be involved in the regulation of protein translation itself. This is important because protein translation is a critical process that is involved in the production of many proteins that are involved in various cellular processes, including signaling pathways, tissue repair, and metabolism.

EIF3IP1 as a Biomarker

EIF3IP1 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. This is because EIF3IP1 has been shown to be involved in the regulation of cellular processes that are linked to the development and progression of these diseases.

For example, EIF3IP1 has been shown to play a role in the regulation of mitochondrial function, which is critical for the development and progression of cancer [7-9]. Additionally, EIF3IP1 has been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway, which is involved in the development and progression of various diseases, including cancer [10-12].

In addition to its role in cellular signaling pathways, EIF3IP1 has also been shown to be involved in the regulation of protein translation itself. This is important because protein translation is a critical process that is involved in the production of many proteins that are involved in various cellular processes, including signaling pathways, tissue repair, and metabolism.

EIF3IP1 as a Drug Target

Given its involvement in various cellular processes that are linked to the development and progression of diseases, as well as its potential as a biomarker, EIF3IP1 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

One approach to targeting EIF3IP1 is to use small molecules that can modulate its activity. This can be done by identifying compounds that interact with EIF3IP1 and modulate its activity, such as inhibitors of the translation of EIF3IP1 [14-16].

Another approach to targeting EIF3IP1 is to use antibodies that can recognize and target EIF3IP1. This can be done by creating antibodies that recognize and bind to EIF3IP1, and then using these antibodies to

Protein Name: Eukaryotic Translation Initiation Factor 3 Subunit I Pseudogene 1

The "EIF3IP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EIF3IP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets